Skip to main content
. 2024 Apr 1;1(4):174–181. doi: 10.5588/ijtldopen.23.0490

Table 2.

Clinical characteristics of study participants.

Characteristics All Benin Cameroon Gambia P-value
n (%) n (%) n (%) n (%)
Symptoms
 Cough 41 (42.0) 14 (40.0) 7 (54.0) 20 (40.0) 0.645
 Current wheeze 54 (55.0) 20 (57.0) 10 (77.0) 24 (48.0) 0.153
 Shortness of breath 29 (30.0) 6 (17.0) 2 (15.0) 21 (42.0) 0.028*
Physician diagnosis
 Asthma 78 (80.0) 29 (83.0) 9 (69.0) 40 (80.0) 0.669
 COPD 16 (16.0) 4 (11.0) 3 (23.0) 9 (18.0)
 Chronic bronchitis 4 (4.0) 2 (6.0) 1 (8.0) 1 (2.0)
Reported exacerbation within last 1 year
 0 47 (48.0) 15 (43.0) 3 (23.0) 29 (58.0) 0.076
 1–2 16 (16.0) 4 (11.0) 3 (23.0) 9 (18.0)
 3–5 18 (18.0) 6 (17.0) 5 (38.0) 7 (14.0)
 >5 17 (18.0) 10 (29.0) 2 (16.0) 5 (10.0)
Level of disease control/disease impact
 ACT
  Good (≥20) 26 (34.0) 6 (23.0) 5 (50.0) 15 (38.0) 0.255
  Poor (≤19) 50 (66.0) 20 (77.0) 5 (50.0) 25 (62.0)
 CAT
  Mild (<10) 2 (10.0) 1 (12.5) 0 (0) 1 (10.0) 0.519
  Moderate(10–20) 13 (62.00) 6 (75.0) 1 (33.0) 6 (60.0)
  Severe (≥21) 6 (28.0) 1 (12.5) 2 (67.0) 3 (30.0)
Spirometry characteristics All Benin Cameroon Gambia P-value
(n = 98) (n = 35) (n = 13) (n = 50)
 Spirometry indices, mean ± SD
  FEV1 (% predicted) 69.7 ± 21.5 66.5 ± 22.2 69.5 ± 25.4 71.2 ± 20.2 0.707
  FVC (% predicted) 83.6 ± 17.7 78.1 ± 16.9 81.7 ± 23.6 86.8 ± 15.6 0.134
  FEV1/FVC ratio 66.5 ± 15.4 63.9 ± 14.6 72.9 ± 14.7 66.7 ± 16.0 0.196
 Spirometry patterns
  Normal 29 (29.6) 8 (22.9) 6 (46.0) 15 (30.0) 0.277
  Airflow obstruction 66 (67.3) 27 (77.1) 7 (54.0) 32 (64.0)
  Restrictive 3 (3.1) 0 0 3 (6.0)
*

χ2 with Yates correction.

COPD = chronic obstructive pulmonary disease; ACT = Asthma Control Test; CAT = COPD Assessment Test; SD = standard deviation; FEV1 = forced expiratory volume in first second; FVC = forced vital capacity.